LA JOLLA PHARMACEUTICAL CO Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 7.88 | 498 | 3,924 | 498 | |
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 6.70 | 498 | 3,337 | 7,823 | 7.3 K to 7.8 K (+6.80 %) |
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.88 | 692 | 5,453 | 692 | |
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.70 | 692 | 4,636 | 80,279 | 79.6 K to 80.3 K (+0.87 %) |
| Jan 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Buy | P | 8.23 | 3,000 | 24,677 | 6,545 | 3.5 K to 6.5 K (+84.63 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.66 | 1,253,878 | 8,351,580 | 7,910,575 | 6.7 M to 7.9 M (+18.84 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.70 | 717,804 | 4,090,909 | 6,656,697 | 5.9 M to 6.7 M (+12.09 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.27 | 400,339 | 2,111,748 | 5,938,893 | 5.5 M to 5.9 M (+7.23 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.80 | 599,661 | 2,880,232 | 5,538,554 | 4.9 M to 5.5 M (+12.14 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 |